-

LaVoieHealthScience Welcomes Katie Dodge as Senior Vice President and General Manager

Focus on Agency, Client Excellence, Growth, People and Best Practices

BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the expansion of its senior leadership team with the appointment of Katie Dodge as Senior Vice President and General Manager of its Boston headquarters.

In her role, Katie is responsible for agency and client excellence in both LHS’ commercial and emerging communication practices with a focus on growth, people, and best practices. She brings a wealth of communications expertise to LHS clients including corporate and product communications media strategy and execution, brand development and management, social media strategy, people management, executive media training, message development and crisis communications.

Donna L. LaVoie, President and Chief Executive Officer of LaVoieHealthScience said, “Katie brings an entrepreneurial mindset to our agency and a record of accomplishment of client success across a portfolio pharmaceutical, biopharma, life science, medical technology, and related fields. We are excited to experience Katie’s leadership with our team and clients, who are dedicated to advancing health and science innovations globally.”

Katie’s entire career has been spent at leading health- oriented communications agencies, including Ruder Finn, Salutem, JPA Health, Weber Shandwick, KYNE, and Edelman. Katie is a graduate of Emerson College with a Bachelor of Science in Marketing Communications.

About LaVoieHealthScience

LaVoieHealthScience partners with health and science emerging and commercial organizations to advance their innovations. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly regulated industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, and digital and creative services.

For more information, please visit lavoiehealthscience.com and connect with us on LinkedIn, X, and Facebook.

Contacts

Agency Contact:
Lisa DeScenza
SVP, Corporate Communications & Investor Relations
(617) 351-0243
ldescenza@lavoiehealthscience.com

Media Contact:
Abby Ramsay
Account Supervisor
(617) 865-9340
aramsay@lavoiehealthscience.com

LaVoieHealthScience


Release Versions

Contacts

Agency Contact:
Lisa DeScenza
SVP, Corporate Communications & Investor Relations
(617) 351-0243
ldescenza@lavoiehealthscience.com

Media Contact:
Abby Ramsay
Account Supervisor
(617) 865-9340
aramsay@lavoiehealthscience.com

More News From LaVoieHealthScience

LaVoie Strategic Communications Group, Inc. Awarded GSA Schedule Contract to Provide Public Relations, Marketing and Training to Federal Agencies

BOSTON--(BUSINESS WIRE)--LaVoie Strategic Communications Group, Inc., widely recognized in the health, science, and medical technology industry as LaVoieHealthScience, has been awarded the first five-year option period of a twenty-year General Services Administration (GSA) Multiple Award Schedule (MAS) contract (Contract Number 47QRAA25D0070) to provide public relations, marketing, and leadership training services to the Federal Government, with an estimated value of $4 million. Under this desi...

LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards

BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)” at this year’s PRWeek Healthcare Awards on May 21. This award is for the partnership with Menarini Stemline from the 2023 launch of ORSERDU® (elacestrant) for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast can...

LaVoieHealthScience Joins Global Communications Network, IPREX

BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience, an integrated IR and PR agency, joins IPREX, the top global communications and PR network in more than 100 markets globally....
Back to Newsroom